Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
ID: 360368Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/360368
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity for administrative supplements to existing NIH grants and cooperative agreements, allowing current recipients to request additional funding for unforeseen increased costs within the scope of their approved projects. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, for-profits, and government entities, provided they hold an active parent award. This opportunity is crucial for supporting ongoing health-related research by addressing unexpected financial needs that arise during the project lifecycle. Interested parties must ensure compliance with submission guidelines and can contact the Division of Grants Policy at GrantsPolicy@od.nih.gov for further information; the application deadline is November 30, 2028.

    Point(s) of Contact
    GrantsPolicy@od.nih.gov
    Files
    Title
    Posted
    PA-26-001-Full-Announcement.html
    The Department of Health and Human Services (HHS), through the National Institutes of Health (NIH), has reissued a funding opportunity (PA-26-001) for administrative supplements to existing NIH grants and cooperative agreements. This opportunity allows current recipients to request additional funds for unforeseen increased costs within the original scope of their peer-reviewed and approved projects. Various NIH institutes and centers are participating, and applications are administratively reviewed rather than peer-reviewed. Eligible organizations include higher education institutions, nonprofits, for-profits, and government entities, provided they hold an active parent award. Applicants must ensure all proposed activities remain within the initial scope of the grant and adhere to strict registration and submission guidelines.
    Similar Opportunities
    AHRQ Administrative Supplements for Grants in Health Services Research
    Agency for Health Care Research and Quality
    The Agency for Healthcare Research and Quality (AHRQ) has announced a Notice of Funding Opportunity (NOFO) for administrative supplements to active AHRQ grants, aimed at addressing unforeseen increased costs associated with approved health services research projects. Eligible applicants, including public and state-controlled institutions of higher education, must hold active AHRQ awards and adhere to specific budget limits, which are capped at 20% of federal direct costs or $100,000 for larger grants, and 10% for smaller projects. This funding opportunity is crucial for supporting ongoing research that enhances healthcare quality and accessibility, particularly for priority populations. Interested parties should submit applications electronically via Grants.gov by the deadlines of June 26, October 26, and February 26 annually, with inquiries directed to GrantQueries@ahrq.hhs.gov.
    Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Supplements to Promote Diversity in Health-Related Research," aimed at enhancing diversity within the health research workforce. This initiative seeks to recruit and support individuals from diverse backgrounds, including underrepresented racial and ethnic groups, individuals with disabilities, and those from disadvantaged backgrounds, while providing necessary accommodations for researchers with disabilities. The funding, which can reach up to $500,000, is available for administrative supplements to existing research grants, with applications undergoing administrative review rather than peer review. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with the application deadline set for May 7, 2026.
    Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for competing revisions to existing Single Project Research Grants and Cooperative Agreements, with the option for clinical trials. This initiative allows NIH award recipients to apply for additional funds to expand their current projects within the relevant Institutes and Centers, specifically in response to Notices of Special Interest (NOSI) issued by participating NIH entities. The funding opportunity, identified as PA-23-317, is open to a wide range of eligible applicants, including higher education institutions, nonprofit organizations, and foreign entities, reflecting NIH's commitment to advancing impactful health research. Applications must be submitted by November 24, 2026, through the NIH ASSIST system or Grants.gov, and will be evaluated based on scientific merit and adherence to specified criteria. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced an Emergency Competitive Revision program aimed at providing funding for applications related to disasters declared under the Stafford Act or public health emergencies. This initiative is designed to support existing NIH awards and facilitate projects that address urgent public health issues stemming from such emergencies. Eligible applicants include a diverse range of organizations, such as higher education institutions, nonprofits, and local governments, particularly those impacted by recent disasters. The funding opportunity, designated as PA-24-201, opens on April 19, 2024, with applications due by April 18, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PA-24-201.html.
    Administrative Supplements to Promote Diversity in Research and Development Small Businesses SBIR/STTR (Admin Supp Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC), is offering administrative supplements aimed at enhancing diversity within the research and entrepreneurial workforce supported by Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants. This funding opportunity is designed to recruit, mentor, and support individuals from underrepresented backgrounds and those with disabilities, facilitating their involvement in ongoing research projects without leading independent clinical trials. The initiative emphasizes the importance of diverse perspectives in advancing health-related research and professional development, with eligible applicants including small businesses and various research candidates. Interested parties should note that the application deadline is October 13, 2027, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PA-24-255.html.
    Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for organizations seeking to change the recipient organization of specific NIH grants. This initiative allows eligible applicants, including higher education institutions, nonprofits, and various government entities, to submit applications for the transfer of grant awards, ensuring continuity in research projects. While the submission of applications does not guarantee approval for the transfer, the NIH encourages coordination with relevant institutes and adherence to grant policies to facilitate a smooth transition. Interested parties can find more information and submit inquiries via email at grantsinfo@nih.gov, with key submission dates starting from July 12, 2024, and the opportunity closing on July 12, 2027.
    Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for organizations holding specific types of NIH grants to submit applications for changes in recipient organization status, known as Successor-in-Interest. This initiative aims to facilitate transitions for organizations while ensuring project continuity, allowing eligible applicants—including various higher education institutions, nonprofits, government entities, and foreign organizations—to propose research that aligns with the original NIH-supported project scope. Applications will undergo an administrative evaluation focusing on compliance with federal regulations, with key dates including an open submission period starting July 19, 2024, and a funding expiration date set for July 18, 2027. Interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing an upcoming funding opportunity titled "Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)," aimed at supporting research that leverages resources from ongoing clinical studies. This initiative encourages applications for ancillary studies that utilize well-characterized patient cohorts, infrastructure, data, and biological samples, while aligning with the mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). With an estimated total program funding of $600,000 and the expectation of awarding two grants, potential applicants are advised to begin developing collaborations and project proposals in advance of the official solicitation, which is expected to be published in early 2026. For further inquiries, interested parties may contact Dr. Heiyoung Park at Heiyoung.Park@nih.gov or by phone at 301-594-5032.
    NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)" aimed at fostering international research collaborations that align with its mission. This grant supports projects that include at least one international subproject and are relevant to the scientific interests of participating NIH Institutes, Centers, and Offices (ICOs). The initiative is crucial for advancing health sciences by leveraging unique resources and expertise available in other countries, which may not be accessible in the United States. Interested applicants can reach out to the NIH Office of Policy for Extramural Research Administration (OPERA) via email at OPERAleadership@mail.nih.gov for further information, with applications due by January 25, 2026, and an estimated award date set for September 1, 2026.
    NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)" aimed at supporting discrete research projects across various scientific fields, excluding clinical trials. This grant encourages applications from a diverse range of eligible entities, including higher education institutions, nonprofits, and organizations serving underrepresented communities, with the goal of fostering innovative research that enhances public health and scientific knowledge. The funding does not impose limits on application budgets, provided they reflect actual project needs, and allows for a maximum project duration of five years. Interested applicants can find more information and guidelines at the NIH grants website and should direct inquiries to grantsinfo@nih.gov, with the application deadline set for January 7, 2028.